Compare ICLR & SEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICLR | SEIC |
|---|---|---|
| Founded | 1990 | 1968 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 9.8B |
| IPO Year | 2001 | 1995 |
| Metric | ICLR | SEIC |
|---|---|---|
| Price | $113.35 | $91.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $178.62 | $104.86 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | N/A | ★ 27.66 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $2,297,381,000.00 |
| Revenue This Year | N/A | $14.61 |
| Revenue Next Year | N/A | $7.25 |
| P/E Ratio | ★ $12.91 | $65.08 |
| Revenue Growth | N/A | ★ 8.10 |
| 52 Week Low | $66.57 | $75.08 |
| 52 Week High | $211.00 | $93.96 |
| Indicator | ICLR | SEIC |
|---|---|---|
| Relative Strength Index (RSI) | 52.69 | 70.97 |
| Support Level | $99.11 | $84.64 |
| Resistance Level | $116.85 | $91.75 |
| Average True Range (ATR) | 5.40 | 2.31 |
| MACD | 0.33 | 0.70 |
| Stochastic Oscillator | 64.88 | 90.91 |
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $99 billion in assets under management. As of December 2025, SEI (including LSV) manages, administers, or advises about $1.9 trillion in assets.